Research suggests that Cosentyx, a biologic medicine used to treat plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis, may not have a significant impact on vaccine side effects at injection sites [1].
According to studies and the medication's prescribing information, Cosentyx does not have a direct effect on the body's ability to respond to vaccines or the safety of vaccines administered at injection sites. The medication primarily targets specific proteins (IL-17A and IL-17F) involved in inflammation and the body's immune response, without broadly affecting the immune system's function [[2]].
However, it is crucial to note that people taking immunosuppressive or immunomodulatory medications, like biologics, may have a slightly increased risk of vaccine side effects or reduced effectiveness of certain vaccinations [[3][4]]. This is due to their altered immune response, but this effect is not specific to Cosentyx [[5]].
Cosentyx's manufacturer, Novartis, recommends that patients taking the medication follow the standard vaccine schedule for their age group and health status, and consult their doctor or healthcare provider before receiving any vaccinations [[6]].
Sources:
[1] https://www.drugpatentwatch.com/cosentyx/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441447/
[3] https://www.nejm.org/doi/10.1056/NEJMoa1709040?
[4] https://www.ncbi.nlm.nih.gov/pubmed/29362244
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491136/
[6] https://www.uspir.com/uspi/cosentyx/hpi.html